SARS-CoV-2 infection and thyroid dysfunction in children

Abstract

The problem of thyroid dysfunction related to SARS-CoV-2 infection remains unclear in children. Therefore, the study aimed to reveal the interrelationship between thyroid dysfunction and COVID-19 severity­ as well as to determine optimal cut-off values for screening for thyroid disorders in children. A total number of 90 children aged from 1 month to 17 years were involved in the study. Patients with known thyroid disease were not recruited for the research. A thyroid panel was assessed for all participants that included: free triiodothyronine (FT3), free thyroxine (FT4), thyroid-stimulating hormone (TSH) and anti-thyroid peroxidase (ATPO) antibodies. Statistical analysis was done using the computer software Statistica 13.0. Research has revealed euthyroid sick syndrome (ESS) in 14.10% of SARS-CoV-2 infected children more often among patients with severe COVID-19 and multisystem inflammatory syndrome (33.33%) compared to mild COVID-19 course (6.67%) and moderate disease severity (8.89%) (P < 0.05). Significant correlation relationships were revealed for next values – FT3 and erythrocyte sedimentation rate (ESR) (rs = -0.22; P < 0.05); FT3 and C-reactive protein (CRP) (rs = -0.33; P < 0.05); FT3 and procalcitonin (rs = -0.43; P < 0.05). The next cut-off values for ESS determination were revealed: ESR 18.5 mm/h (AUC 0.803); CRP 11.5 mg/l (AUC 0.763); ferritin 84.8 ng/ml (AUC 0.733). Results suggest that pediatricians should pay attention to the endocrine disruptions by COVID-19 in children. Keywords: COVID-19, euthyroid sick syndrome in children, inflammatory markers

The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism

“…Data from the USA reported an MIS-C frequency of 316 cases per million confirmed SARS-CoV-2 episodes in persons aged <21 [ 3 ]. Recent studies underline that critical illness or even death among children with COVID-19 is most commonly seen in patients with comorbidities (respiratory, cardiovascular disorders, obesity, neurological or oncological disease) and the presence of co-infections [ 3 , 4 , 5 ]. In addition, age is an important risk factor for disease severity—premature babies, infants and adolescents are at greater risk for poor COVID-19 outcomes [ 3 , 5 , 6 ].…”